ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

In Brief: Stipends Out For Trainees In new Clinical Program, But They Can Be Paid If Any Money Is Available

May 31, 1974

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

Insufficient Data To Prove Digital Mammograms Better, Michigan Consortium Finds

August 29, 2003

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

In Brief: Hammer Appointed To New Three Year Term, Says As Panel Chairman; ACCC Elects Yarbro, Moorhead

March 16, 1984